Human Interleukin-15, IL-15. T-cell and NK cell activation

IL15
$228.00$880.00
Availability
Quantity

Specification

Name

Human Interleukin-15, IL-15 (Asn49 to Ser162)

Primary Accession ID

P40933

Family

Cytokine/Growth Factor

Molecular Weight

12.8 kDa

Source

E Coli

Storage Temperature

Store at -20 °C or -80 °C for extended shelf life

Shipping

Store liquid at 2 – 8 °C | with ice
IL15
$228.00$880.00
Availability
Quantity

Description

Human Interleukin-15 (IL-15) is a cytokine with a molecular weight of approximately 14 kDa, consisting of 114 amino acids arranged in a four-helix bundle structure. It is predominantly produced by monocytes and macrophages and plays a crucial role in the development, survival, and function of natural killer (NK) cells and memory CD8+ T cells. IL-15 is essential for maintaining the homeostasis and functionality of these key components of the immune system.

IL-15 binds to its specific receptor, IL-15Rα, and shares the common β and γ chains with IL-2, which are part of the IL-2 receptor complex. This interaction activates several intracellular signaling pathways, including JAK1/3-STAT5 and PI3K. These pathways are critical for promoting cell survival, proliferation, and immune responses.

Key Features

  1. NK and T Cell Activation: IL-15 is vital for the development and maintenance of NK cells and CD8+ memory T cells. It supports their survival, proliferation, and cytotoxic function, thereby playing a key role in long-term immune defense and response to infections.
  2. Research Applications: IL-15 is extensively studied in cancer immunotherapy and vaccine adjuvant development. Its ability to enhance the activity and persistence of NK and T cells makes it a valuable tool for improving therapeutic strategies and vaccine efficacy.
  3. Anti-Tumor Immunity: IL-15 significantly boosts the anti-tumor activity of NK cells and CD8+ T cells, contributing to the development of novel cancer treatments. Its role in enhancing immune responses against tumors is a major focus of ongoing research and clinical trials.

Sequence

 49
NW
 60
VNVISDLKKI
 70
EDLIQSMHID
 80
ATLYTESDVH
 90
PSCKVTAMKC
 100
FLLELQVISL
 110
ESGDASIHDT
 120
VENLIILANN
 130
SLSSNGNVTE
 140
SGCKECEELE
 150
EKNIKEFLQS
 160
FVHIVQMFIN
 162
TS

Theoretical pI/Mw

4.52 / 12773.50

Recommended Products